USE OF MGLUR5 ANTAGONISTS FOR THE TREATMENT OF PRURITIC CONDITIONS

Details for Australian Patent Application No. 2002231777 (hide)

Owner NOVARTIS AG

Inventors GASPARINI, Fabrizio; URBAN, Laszlo; MEINGASSNER, Josef, Gottfried

Pub. Number AU-A-2002231777

PCT Pub. Number WO2002/062323

Priority 0103045.1 07.02.01 GB

Filing date 6 February 2002

Wipo publication date 19 August 2002

International Classifications

A61K 031/00

A61K 031/44 - Non-condensed pyridines

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/444

A61P 017/04 Drugs for dermatological disorders

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002231777

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231778-METHOD AND DEVICE OR FILLING A CAVITY WITH SLURRIED EXPLOSIVE

2002231776-METHOD FOR PRODUCING A LIGHTEMITTING DEVICE AND A CORRESPONDING LIGHT-EMITTING DEVICE